475 results on '"Waszkielewicz A"'
Search Results
2. Xanthone Derivatives and Their Potential Usage in the Treatment of Telangiectasia and Rosacea
3. Sirtuins as a potential molecular target of cosmetic ingredients
4. Xanthone Derivatives and Their Potential Usage in the Treatment of Telangiectasia and Rosacea
5. Enhanced one-photon and two-photon excited luminescence of polymer-stabilized AuAg nanoclusters aggregates
6. Xanthone Derivatives in the Fight against Glioblastoma and Other Cancers
7. EchoVis: Training Echolocation Using Binaural Recordings - Initial Benchmark Results.
8. EchoVis: Training Echolocation Using Binaural Recordings – Initial Benchmark Results
9. Enhancing general spatial skills of young visually impaired people with a programmable distance discrimination training: a case control study
10. Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone
11. Involvement of the NO/sGC/cGMP/K+ channels pathway in vascular relaxation evoked by two non-quinazoline α1-adrenoceptor antagonists
12. DNA liquid crystals doped with AuAg nanoclusters: One-photon and two-photon imaging
13. Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT2A and α2-adrenoceptor antagonistic properties. A comparison with ketanserin, sarpogrelate, prazosin, yohimbine and ARC239
14. Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist
15. Novel xanthone derivatives as potent sirtuin 2 inhibitors
16. HBK-14 and HBK-15, triple 5-HT1A, 5-HT7 and 5-HT3 antagonists with potent antidepressant- and anxiolytic-like properties, increase seizure threshold in various seizure tests in mice
17. Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3
18. Novel Xanthone Derivatives Impair Growth and Invasiveness of Colon Cancer Cells In Vitro
19. Contribution of reactive oxygen species to the anticancer activity of aminoalkanol derivatives of xanthone
20. Anti-Helicobacter pylori activities of selected N-substituted cinnamamide derivatives evaluated on reference and clinical bacterial strains
21. Single Administration of HBK-15—a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist—Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone
22. Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents
23. Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols
24. MH-76, a Novel Non-Quinazoline α1-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats
25. Gold Nanoclusters Display Low Immunogenic Effect in Microglia Cells
26. Sirtuins as a potential molecular target of cosmetic ingredients
27. Enhancing general spatial skills of young visually impaired people with a programmable distance discrimination training: a case control study
28. Xanthone Derivatives in the Fight against Glioblastoma and Other Cancers
29. N-[(2,6-Dimethylphenoxy)alkyl]aminoalkanols—their physicochemical and anticonvulsant properties
30. Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system
31. Promising anticonvulsant and/or analgesic compounds among 5‐chloro‐2‐ or 5‐chloro‐4‐methyl derivatives of xanthone coupled to aminoalkanol moieties—Design, synthesis and pharmacological evaluation
32. Promising anticonvulsant and/or analgesic compounds among 5-chloro-2- or 5-chloro-4-methyl derivatives of xanthone coupled to aminoalkanol moieties - design, synthesis and pharmacological evaluation
33. HBK-14 and HBK-15 with antidepressant-like and/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice
34. HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling
35. KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain
36. Anticonvulsant evaluation of aminoalkanol derivatives of 2- and 4-methylxanthone
37. KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain
38. Design, synthesis, and anticonvulsant activity of some derivatives of xanthone with aminoalkanol moieties
39. Design, Synthesis and Anticonvulsant Activity of New Phenoxyalkyl, Phenoxyethoxyethyl and Phenoxyacetyl Derivatives of Aminoalkanols
40. Sirtuins as a potential molecular target of cosmetic ingredients
41. Nonlinear absorption in nanosystems of biological significance.
42. Chemically homogenous compounds with antagonistic properties at all α1-adrenoceptor subtypes but not β1-adrenoceptor attenuate adrenaline-induced arrhythmia in rats
43. HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats.
44. Influence of the position of the methyl substituent and N-oxide formation on the geometry and intermolecular interactions of 1-(phenoxyethyl)piperidin-4-ol derivatives
45. Sirtuins as a potential molecular target of cosmetic ingredients
46. Design, synthesis and anticonvulsant activity of new phenoxyalkyl, phenoxyethoxyethyl and phenoxyacetyl derivatives of aminoalkanols
47. Synthesis and anticonvulsant activity of trans- and cis-2-(2,6-dimethylphenoxy)-N-(2- or 4-hydroxycyclohexyl)acetamides and their amine analogs
48. Influence of protonation on the geometry of 2-{[(2,6-dimethylphenoxy)ethyl]amino}-1-phenylethan-1-ol: crystal structures of the free base and of its chloride and 3-hydroxybenzoate salt forms
49. Influence of protonation on the geometry of 2-{[(2,6-dimethylphenoxy)ethyl]amino}-1-phenylethan-1-ol: crystal structures of the free base and of its chloride and 3-hydroxybenzoate salt forms
50. Antimutagenic compounds and their possible mechanisms of action
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.